Pfizer's RSV vaccine approved by FDA for older adults.

1 min read
Source: CNN
Pfizer's RSV vaccine approved by FDA for older adults.
Photo: CNN
TL;DR Summary

The FDA has approved Pfizer's RSV vaccine for older adults, making it the second vaccine approved for the common virus. RSV is highly contagious and can cause flu-like illness in people of all ages, including seniors. The Pfizer vaccine was found to be 66.7% effective at preventing moderate lower respiratory tract illness and 85.7% effective at preventing illness with three or more symptoms in people 60 and older. The vaccine could be available for seniors by fall pending recommendations from the CDC.

Share this article

Reading Insights

Total Reads

0

Unique Readers

9

Time Saved

1 min

vs 2 min read

Condensed

73%

30082 words

Want the full story? Read the original article

Read on CNN